(Q30746410)

26 June 2017

title

Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus (English)

1 reference

26 June 2017

1 reference

5

Stanislav Miertus

1 reference

26 June 2017

4

Sabrina Pricl

1 reference

26 June 2017

Vladimír Frecer

1

1 reference

26 June 2017

Martin Kabelác

series ordinal

2

1 reference

26 June 2017

Piergiuseppe De Nardi

series ordinal

3

1 reference

26 June 2017

publication date

1 January 2004

1 reference

Journal of Molecular Graphics & Modelling

26 June 2017

published in

1 reference

26 June 2017

volume

22

1 reference

26 June 2017

issue

3

1 reference

26 June 2017

page(s)

209-220

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

26 June 2017

1 reference

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Therapy for acute hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Conservation and variability in the structures of serine proteinases of the chymotrypsin family

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Substrate specificity of the hepatitis C virus serine protease NS3.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Product inhibition of the hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Optimization of the P'-region of peptide inhibitors of hepatitis C virus NS3/4A protease

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Solid phase synthesis of aminoboronic acids: potent inhibitors of the hepatitis C virus NS3 proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Novel hepatitis C virus protease inhibitors: thiazolidine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Structure-activity relationship studies of a bisbenzimidazole-based, Zn(2+)-dependent inhibitor of HCV NS3 serine protease

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Generalized born models of macromolecular solvation effects

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Protonation-state dependence of hydrogen bond strengths and exchange rates in a serine protease catalytic triad: bovine chymotrypsinogen A

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2803%2900161-X

7 January 2021

10.1016/S1093-3263(03)00161-X

Identifiers

DOI

1 reference

26 June 2017

1 reference